4.7 Review

Evasion of innate immunity by Mycobacterium tuberculosis: is death an exit strategy?

Journal

NATURE REVIEWS MICROBIOLOGY
Volume 8, Issue 9, Pages 668-674

Publisher

NATURE PUBLISHING GROUP
DOI: 10.1038/nrmicro2387

Keywords

-

Categories

Funding

  1. US National Institutes of Health [R01 AI073774]
  2. NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI067731, R01AI073774, R01AI072143, R56AI084161] Funding Source: NIH RePORTER

Ask authors/readers for more resources

Virulent Mycobacterium tuberculosis inhibits apoptosis and triggers necrosis of host macrophages to evade innate immunity and delay the initiation of adaptive immunity. By contrast, attenuated M. tuberculosis induces macrophage apoptosis, an innate defence mechanism that reduces bacterial viability. In this Opinion article, we describe how virulent M. tuberculosis blocks production of the eicosanoid lipid mediator prostaglandin E-2 (PGE(2)). PGE(2) production by infected macrophages prevents mitochondrial damage and initiates plasma membrane repair, two processes that are crucial for preventing necrosis and inducing apoptosis. Thus, M. tuberculosis-mediated modulation of eicosanoid production determines the death modality of the infected macrophage, which in turn has a substantial impact on the outcome of infection.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available